| Date | Title | Description |
| 17.12.2025 | Bioptimus Unveils M-Optimus, a World Model for Biology | Revolutionary model represents a transformative step toward AI-powered virtual tissues, patient digital twins, and a new era of data-driven biomedical innovation
The Unveiling of M-Optimus: Bioptimus has trained its inaugural World Model fo... |
| 24.09.2025 | Proscia to Expand Pathology AI Capabilities with Virtual Staining | , a pathology AI company, is introducing virtual staining in its Concentriq software platform to help laboratories reduce the costs associated with traditional chemical methods and drive efficiency in high-throughput workflows. The virtual ... |
| 24.09.2025 | Proscia® Launches Virtual Staining to Transform Digital Pathology with AI | What You Should Know:
– Proscia®, a pathology AI company, has introduced a new virtual staining feature in its Concentriq® software platform.
– The technology, powered by Pictor Labs, is designed to help laboratories reduce the costs and ti... |
| 10.09.2025 | Proscia Launches AI Solution to Advance Precision Medicine | What You Should Know:
– Proscia®, a pathology AI company, has announced the launch of Proscia Aperture™, a new precision medicine solution designed to automatically identify eligible patients for clinical trials at the moment of diagnosis.
... |
| 20.03.2025 | Proscia's $50M Funding: A Leap into the Future of Digital Pathology | In the world of healthcare, time is often the enemy. Patients wait, sometimes for months, for diagnoses that can change their lives. Proscia, a software company at the forefront of digital pathology, is on a mission to change that. With a r... |
| 19.03.2025 | Proscia Secures $50M to Accelerate AI-Driven Digital Pathology | What You Should Know:
– Proscia, a software company focused on digitizing and applying AI to pathology, has announced a $50M funding round, bringing its total capital raised to $130M.
– The funding, led by Insight Partners, AI Capital Partn... |
| 19.03.2025 | Proscia Raises $50M in Funding | Proscia, a Philadelphia, PA-based software company improving pathology’s transition to digital and AI, raised $50M in funding.
The round, which brought the total amount to $130M, was led by Insight Partners along with AI Capital Partners (A... |
| 19.03.2025 | Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicine | Proscia is rewiring pathology to speed up the development of targeted therapies, accelerate diagnosis, and match more patients with the best course of treatment
Funding led by global software investor Insight Partners comes as the surge in ... |
| 07.11.2024 | Q/A: Proscia Co-Founder Talks Impact of DICOM in Digital Pathology | Nathan Buchbinder, Co-Founder and Chief Strategy Officer at Proscia
The world of digital pathology is undergoing a significant transformation, with the adoption of DICOM (Digital Imaging and Communications in Medicine) emerging as a game-ch... |
| 03.10.2024 | Accelerating Drug Discovery: Proscia Launches Concentriq Embeddings and AI Toolkit | What You Should Know:
– Proscia, a provider of AI-powered pathology solutions, is accelerating the pace of drug discovery and diagnostic development with the launch of Concentriq® Embeddings and the Proscia AI Toolkit.
– These powerful new ... |
| 02.10.2024 | Proscia Launches Concentriq Embeddings and Developer Toolkit to Unleash Pathology AI Development | Life sciences organizations can rapidly build AI algorithms to discover biomarkers, optimize clinical trials, and advance companion diagnostics—powered by the first digital pathology platform to seamlessly integrate foundation models
PHILAD... |
| 13.03.2024 | Proscia’s $46M Series C propels AI-driven pathology into the mainstream | Join leaders in Boston on March 27 for an exclusive night of networking, insights, and conversation. Request an invite here.
Proscia, a leading provider of digital pathology software, announced today that it has raised $9 million in an exte... |
| 16.02.2024 | FDA Clears Proscia’s AI-Powered Digital Pathology Solution for Cancer Diagnosis | What You Should Know:
Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) clearance from the United States (U.S.) Food and Drug Administration (FDA) for its Concentriq® AP-Dx*. The digital patho... |
| 16.02.2024 | FDA Clears Proscia’s Digital Pathology Solution for Cancer Diagnosis | What You Should Know:
Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) clearance from the United States (U.S.) Food and Drug Administration (FDA) for its Concentriq® AP-Dx*. The digital patho... |
| 08.12.2023 | CellNetix Selects Proscia To Deliver New Standard Of Excellence In Pathology | Modernizing the 150-year-old microscope-based practice with digital innovation
CellNetix Pathology & Laboratories, one of the largest independent pathology service providers in the United States, is innovating its practice with digital ... |
| 29.06.2023 | Roundups: 22 Recent Strategic Digital Health Partnerships | Advantus Health Partners forms a new 10-year, $2.9B strategic partnership with Medline to establish agility and scale, supply chain resiliency and enhanced clinical integration with the nurses and physicians who use Medline’s product. This ... |
| 20.06.2023 | Mindpeak and Proscia Partner to Improve Cancer Diagnosis with Integrated AI-Powered Pathology Workflows | "Mindpeak’s IHC quantification algorithms are already helping pathologists make faster, more informed decisions to advance the quest for precision medicine. We're looking forward to incorporating them into our ecosystem." - Stepha... |
| 13.06.2023 | 70% Of Major Pharmaceutical Companies And CROs Surveyed Have Adopted Digital Pathology | "The results of the 2023 Life Sciences Digital Pathology Adoption Survey confirms that digital pathology has earned its place on the C-suite agenda across life sciences organizations,” said David West, Proscia’s CEO
PHILADELPHIA (PRWEB... |
| 05.06.2023 | Digital Pathology in Preclinical R&D Services: Barriers and Opportunities for Acceleration, Upcoming Webinar Hosted by Xtalks | In this webinar, the featured speakers will dive into the current and future state of histopathology and histology R&D.
TORONTO (PRWEB) June 05, 2023
Digital pathology has been instrumental in accelerating preclinical R&D workflows ... |
| 01.05.2023 | Using Digital Pathology to Accelerate Preclinical R&D, Upcoming Webinar Hosted by Xtalks | Leading pharmaceutical companies, biotechnology companies, and contract research organizations (CROs) are rapidly adopting digital pathology to drive efficiency and quality gains in their preclinical studies while capitalizing on the promis... |
| 24.04.2023 | Virscio Deploys Proscia’s Software To Improve Efficiency Of Drug Research And Development | Virscio is leveraging Concentriq for Research to unify its teams and pathology data across GLP and non-regulated preclinical studies. “Translating concept to clinical success requires innovative technology, and we’ve found this in Concentri... |
| 21.03.2023 | Altasciences Selects Proscia To Accelerate The Development Of Life-Saving Drugs | “Our decision to adopt digital pathology and chart our course with Proscia strongly reflects Altasciences’ guiding focus on ensuring our sponsors’ success,” said Dr. Wendell P. Davis, Vice President of Pathology.
LAVAL, Québec and PHILADELP... |
| 20.03.2023 | Proscia Announces Major Expansion In Preclinical R&D To Drive Faster Drug Safety Decisions | "Expanding our solutions for preclinical R&D came in response to customer demand. We are helping them to increasingly realize the efficiency and quality gains that Concentriq for Research delivers as the place where work happens an... |
| 13.03.2023 | Spectrum Healthcare Partners Taps Proscia To Democratize Cancer Diagnosis | "We believe that all patients, regardless of geography, deserve access to high-quality care,” said Bilal R. Ahmad, MD, MBA, FCAP, Managing Director, Pathology Division at Spectrum Healthcare Partners. "Concentriq Dx is critical to... |
| 01.03.2023 | PathGroup Chooses Proscia To Deliver Next Generation Of Cancer Diagnosis For Millions of Patients | "We are thrilled that Proscia shares our vision for a fully digital future," said Ben W. Davis, MD, CEO of PathGroup.
NASHVILLE, Tenn. and PHILADELPHIA (PRWEB) March 01, 2023
Proscia®, a leading provider of digital and computation... |
| 01.03.2023 | PathGroup Expands Operations with Proscia Concentiq Dx | What You Should Know:
– PathGroup, one of the largest providers of anatomic, clinical, digital, and molecular pathology services in the United States, is expanding its operations with Proscia’s software platform (Concentriq® Dx) to further ... |
| 16.02.2023 | Proscia Builds Momentum In Life Sciences Market Led By Customer And Product Growth | Beyond powering R&D at scale today, Concentriq for Research will enable research teams to capitalize on new opportunities that reimagine the potential of pathology data in advancing how we treat patients for years to come. -David West, ... |
| 26.01.2023 | The Benefits of Digital Pathology with Automated Quality Control for Accelerating Drug Discovery, Upcoming Webinar Hosted by Xtalks | Quality challenges are costly and disruptive, particularly if a rescan is initiated by a scientist or pathologist whose valuable time is being diverted away from analysis to address quality issues.
TORONTO (PRWEB) January 26, 2023
Digital p... |
| 18.01.2023 | Netherlands Cancer Institute to Deploy Proscia’s Pathology Platform | What You Should Know:
CE-marked under IVDR, Concentriq Dx is a singular, secure digital pathology platform that drives primary diagnostic and other routine workflows across the connected laboratory.* NKI will draw on the platform’s world-cl... |
| 18.01.2023 | Netherlands Cancer Institute (NKI) Selects Proscia To Drive Personalized Diagnosis | "Concentriq Dx will empower us to chart our path towards full digitization. The modern, enterprise-grade platform will enable us to increasingly combine expertise and insight to drive precision diagnosis." - José van den Berg, Hea... |
| 03.01.2023 | PathGroup Expands Operations with Proscia Concentriq Dx | What You Should Know:
– PathGroup, one of the largest providers of anatomic, clinical, digital, and molecular pathology services in the United States, is expanding its operations with Proscia’s software platform (Concentriq® Dx) to further ... |
| 15.11.2022 | Proscia To Showcase Improvements In Artificial Intelligence Generalization At The Conference On Neural Information Processing Systems | If you can’t build AI that generalizes to new sites, you can’t build AI that makes an impact. Beyond potentially improving melanoma detection, our work highlights the importance of key aspects of training AI that often go overlooked. - Juli... |
| 01.11.2022 | Proscia Presents Study Results On New Artificial Intelligence That Predicts Diagnostic Concordance For Melanoma | Proscia's AI relies on self-supervised learning to identify similar patterns in pathology images - much like a human sorting puzzle pieces. "Proscia’s technology signals an exciting advancement as pathologists increasingly turn to AI t... |
| 14.10.2022 | David West, co-founder and CEO of Proscia, on VatorNews podcast | Proscia is a company using AI to aid in cancer diagnosis
Vator · Interview with David West, co-founder and CEO of Proscia
Steven Loeb speaks with David West, co-founder and CEO of Proscia, a company using AI to aid in cancer diagnosis.
Our ... |
| 12.10.2022 | Proscia Releases New Version Of Concentriq Dx Enabling Laboratories To Achieve 100% Digital Diagnosis | “Achieving full digitization requires a platform that provides end-to-end functionality, an effortless user experience, and scalability. Concentriq Dx is the only platform I’ve seen that successfully delivers on all three of these pillars.&... |
| 15.06.2022 | Digital pathology player Proscia procures $37M to expand its reach | Shortly after garnering a European green light for its digital pathology platform, the software developer Proscia has posted a $37 million venture capital round to help expand its commercial reach and seek additional product approvals.
The ... |
| 15.06.2022 | Sequoia Capital published 3 new survival guides for startups | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Free cash flow. Reduce risk. Go FOF yourself.
Paid Content How Northrop Grumman uses ESG as an en... |
| 14.06.2022 | With plans to add 40 to its workforce this year, digital pathology company Proscia raised a $37M Series C | Like most industries, COVID-19 disrupted digital pathology company Proscia‘s plans for growth.
But unlike many, the virus accelerated operations for the eight-year-old Center City company.
“Covid served as an unexpected catalyst for digital... |
| 14.06.2022 | Using AI to aid in cancer diagnosis, Proscia raises $37 million | Proscia's solution is currently being used 10 of the top 20 pharmaceutical companies
The number of people who have cancer around the world is expected to reach 28.4 million cases in 2040, a 47% rise from 2020. At the same time, from 2007 to... |
| 14.06.2022 | Proscia Raises $37M in Series C Funding | Proscia, a Philadelphia, PA-based provider of digital and computational pathology solutions, raised $37M in Series C funding.
The round was led by Highline Capital Management, Triangle Peak Partners, and Alpha Intelligence Capital with part... |
| 14.06.2022 | Proscia Raises $37M for AI-Enabled Pathology Platform | What You Should Know:
– Proscia, a Philadelphia-based provider of digital and computational pathology solutions raises $37M to advance the way we understand and treat diseases like cancer. The round includes participation from Highline Capi... |
| 16.03.2022 | Proscia and Siemens Healthineers Expands Global Reach of Digital Pathology | What You Should Know:
– Proscia®, a digital and computational pathology solution announced a multi-year OEM agreement with Siemens Healthineers.
– Under the agreement, Siemens Healthineers will enter the market by combining its Syngo Carbon... |
| 16.03.2022 | Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration | Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Glooko, a leading provider of remote patient monitoring and data management solutions for diabet... |
| 23.12.2021 | Why Digital Pathology Platform Adoption Will Fail Without Intoperability | Coleman Stavish, CTO, Proscia
The global pandemic has cast a spotlight on the impact of digital transformation in healthcare. From ensuring access to care with telemedicine to accelerating vaccine development, technology has rapidly unlocke... |
| 28.10.2021 | Today's entrepreneur: David West, co-founder and CEO of Proscia | Great people are key to success. It’s hard to over-index talent.
Today's entrepreneur is David West, co-founder and CEO of Proscia, a company that uses AI to help pathologists to improve patient outcomes.
Proscia's platform is called Concen... |
| 05.10.2021 | Proscia Announces Artificial Intelligence Breakthrough in Melanoma Detection | Proscia, a leading provider of digital and computational pathology solutions, has released study results on new technology that leverages artificial intelligence (AI) to automatically detect melanoma, the deadliest form of skin cancer, with... |
| 16.06.2021 | Proscia Lauded by Frost & Sullivan for Advancing the Standard of Cancer Research and Diagnosis with Its Concentriq(R) Platform | Proscia's differentiated approach to AI enablement and advanced features helps geographically distributed teams carry out their routine work from within a shared platform
SANTA CLARA, Calif., June 16, 2021 /PRNewswire/ -- Based on its recen... |
| 02.12.2020 | Daily funding roundup - Dec. 1st, 2020 | WaveOne has raised $6.5M; Databand landed $14.5M; Proscia has secured $23M
Reposite: Reposite is a New York-based maker of a database that helps travel agents manage suppliers and clients, track proposals. Reposite and better manage their b... |
| 01.12.2020 | Proscia Raises $23M in Series B Funding | Proscia, a Philadelphia, PA-based provider of digital and computational pathology solutions, secured $23m in Series B funding.
The round, which brought its funding total to $35m, was led by Scale Venture Partners, with participation from Hi... |
| 01.12.2020 | Computational pathology company Proscia lands $23M in Series B funding | |
| 01.12.2020 | Digital pathology platform Proscia raises $23M | The company uses AI to help pathologists to improve patient outcomes
The way that pathology has traditionally been practiced for the last 150 years involves a human viewing tissue, such as biopsies, on a glass slide under a microscope in or... |
| 01.12.2020 | Proscia Captures $23M Series B For Digital Pathology Software | 15 Shares Email Facebook Twitter LinkedIn
Proscia is moving pathology from the glass slide into the digital age.
Subscribe to the Crunchbase Daily
Pathology has been generally unchanged for 150 years. The process involves taking a piece of ... |
| 20.10.2020 | JPC Taps Proscia to Modernize World’s Largest Human Tissue Repository | What You Should Know:
– The U.S. government’s Joint Pathology Center, which houses the world’s largest human tissue repository, today announced that Proscia, a leading digital and AI pathology company, will provide end-to-end modernization ... |
| 23.06.2020 | Digitizing And Automating Unsung Heroics: The Case Of Pathology | Magnified image from Proscia's platform.Proscia |
| 03.10.2018 | This Week in Jobs: Just Don’t Be Like Elon | Editor’s Note: Every week we ship an email newsletter featuring the region’s most exciting career opportunities. We’ve lovingly called it This Week in Jobs (aka TWIJ (“twidge”) here at Technical.ly HQ). Below is this week’s edition. (Here’s... |
| 26.09.2018 | Proscia Closes $8.3M Series A Round of Financing | Proscia, a Philadelphia, PA-based developer of digital pathology software, closed an $8.3m Series A financing.
The round was led by Flybridge Capital Partners with participation from Emerald Development Managers, Fusion Fund, Razor’s Edge V... |
| 26.09.2018 | Proscia Raises $8M for AI-Enhanced Digital Pathology for Cancer Diagnosis | Proscia, a Philadelphia-based digital pathology platform has raised $8.3 million in Series A funding led by Boston-based Flybridge Capital Partners with participation from Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures, an... |
| 26.09.2018 | Term Sheet — Wednesday, September 26 | THE UNRAVELING
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boundaries From ExtraHop
The departures make sense given that Social Capital is no longer a venture firm but rather a “technology holding company.... |
| 26.09.2018 | Digital pathology startup Proscia lands $8.3M | |
| 26.09.2018 | Proscia wraps up $8.3M Series A to expand digital pathology platform | Based in Philadelphia, Pennsylvania, the startup relies on the image analysis of machines to augment how pathologists diagnose cancer. Rather than simply relying on a microscope, pathologists can utilize Proscia’s AI-powered methods to asse... |
| 13.04.2018 | Proscia is moving its HQ from Baltimore to Philly | Proscia started off the year with a series of partnerships that will help expand its digital pathology platform, as well as new hires. The startup is also moving.
Within a few weeks, the company is planning to relocate its headquarters and ... |
| 22.01.2018 | Here are the 20 best startups in Baltimore right now: realLIST 2018 | There are lots of ways for a startup to stand out, form big hires to notable investors to memorable pitches.
Along with all the work of setting up a company, growth can be a little dizzying. So both inside Technical.ly and from the communit... |
| 19.10.2017 | AI-powered pathology is transforming cancer care | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
In May, Sundar Pichai, CEO of Google, discussed A... |
| 11.07.2017 | Proscia wants to bridge technology gap in cancer research | The goal is to balance the technology needs of pathologists with more cost effective ways to bring this technology to labs and address the storage needs that come with viewing, saving and sharing images. To date, the business has amassed ne... |
| 16.06.2017 | Meet Elizabeth Galbut, Founding Partner at SoGal Ventures | Galbut also founded A-Level Capital, a student-led venture capital firm, while at Johns Hopkins
Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh how times have changed. While the... |
| 06.07.2016 | Proscia CEO: Digital pathology is at inflection point | West said the funding would be used to add staff across software development and sales and marketing, including a director of sales position. He said the team built Proscia’s storage and distribution infrastructure to house its image analys... |
| 05.07.2016 | Pathology software startup using data analytics to aid cancer diagnosis has raised $1M | “Precision medicine in the fight against cancer saves lives and long term healthcare costs,” said David West Jr., president and CEO of Proscia in a statement. “Like digital imaging did for radiology, our software will usher in a new era of ... |
| 05.07.2016 | Digital Pathology Company Proscia Raises $1M | Proscia Inc., a Baltimore, Maryland-based provider of data solutions for digital pathology, raised $1M in seed funding.
The round was led by Emerald Development Managers, with participation from Robin Hood Ventures, TCP Venture Capital and ... |
| 05.07.2016 | Proscia Closes $1 Million Seed Round, Hiring Expected | Two-year-old health IT startup Proscia closed a $1 million seed round, CEO David West, Jr. said Monday.
The round was led by New York-based Emerald Development Managers. Also participating was TCP Venture Capital through its Propel Baltimor... |
| 01.07.2015 | Proscia wants all patients to have access to accurate cancer diagnoses | When they’re reviewing cancer biopsies and making diagnoses, hospitals often require doctors to get a second opinion. But in the highly specialized field, there’s not always another specialist in the house.
That’s where Proscia’s latest fea... |
| 28.04.2015 | This JHU startup wants to make sure doctors analyze cancer biopsies right — every time | For 150 years, the way cancer specialists looked at biopsies didn’t change much. Specialists would gather around a microscope, and analyze slides of showing tissue specimens.
“That’s ridiculous,” says Johns Hopkins University biomedical eng... |
| - | Proscia | “Concentriq, our digital pathology platform, is redefining the pathology laboratory. Learn about our AI-powered, computational pathology software here.” |
| - | Pathology software startup using data analytics to aid cancer diagnosis has raised $1M | Proscia, a health IT startup that developed a platform for digital pathology software aimed at clinicians and researchers to make the process of sharing and storing data easier to support cancer diagnoses and treatment, has raised $1 millio... |
| - | Digital pathology companies score partnerships with marquee providers to leverage ML on image analysis | On March 10, Cleveland Clinic and Boston-based PathAI announced they are partnering to deploy PathAI’s artificial intelligence pathology algorithms for research as well as improving patient care. Specifically, the collaboration will enable ... |
| - | Proscia Unveils New Enhancements to its Digital Pathology Platform | What You Should Know:
A recent analysis of the 2021 College of American Pathologists’ Practice Leader Survey indicates that only 65% of practices looking to hire pathologists could fill all open positions, marking a decline from 2017. This ... |
| - | Proscia wants to bridge technology gap in cancer research | Proscia image analysis, digital pathology
A digital pathology startup founded by technologists from Johns Hopkins, Moffitt Cancer Center in Tampa, the Ohio State University College of Medicine, and the University of Pittsburgh wants to shak... |
| - | Proscia CEO: Digital pathology is at inflection point | If you were looking for some major milestone events indicating the level of interest in digital pathology, you could focus on last week when Philips acquired tumor analysis business PathXL, based in Belfast, Northern Ireland. A couple of ye... |
| - | Proscia wraps up $8.3M Series A to expand digital pathology platform | Proscia, a startup leveraging technology to help diagnose cancer, has raised an $8.3 million Series A round led by Flybridge Capital Partners. Fusion Fund, Emerald Development Managers, Razor’s Edge Ventures and Robin Hood Ventures also par... |
| - | Proscia Closes $8.3M Series A Round of Financing | Proscia, the pioneer in the development and advancement of digital pathology, has closed an $8.3 million round of Series A financing from a group of East and West Coast venture capital firms. The funding was led by Boston-based Flybridge Ca... |
